PL2941434T3 - Środki kontrastujące na bazie manganu do rezonansu magnetycznego - Google Patents

Środki kontrastujące na bazie manganu do rezonansu magnetycznego

Info

Publication number
PL2941434T3
PL2941434T3 PL14735166T PL14735166T PL2941434T3 PL 2941434 T3 PL2941434 T3 PL 2941434T3 PL 14735166 T PL14735166 T PL 14735166T PL 14735166 T PL14735166 T PL 14735166T PL 2941434 T3 PL2941434 T3 PL 2941434T3
Authority
PL
Poland
Prior art keywords
manganese
magnetic resonance
resonance imaging
contrast agents
based contrast
Prior art date
Application number
PL14735166T
Other languages
English (en)
Inventor
Peter Caravan
Eirc M. GALE
Galen S. Loving
Shreya Mukherjee
Jiang Zhu
Original Assignee
The General Hospital Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corporation filed Critical The General Hospital Corporation
Publication of PL2941434T3 publication Critical patent/PL2941434T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/0035—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Soft Magnetic Materials (AREA)
PL14735166T 2013-01-07 2014-01-07 Środki kontrastujące na bazie manganu do rezonansu magnetycznego PL2941434T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361749614P 2013-01-07 2013-01-07
EP14735166.2A EP2941434B1 (en) 2013-01-07 2014-01-07 Manganese-based magnetic resonance contrast agents
PCT/US2014/010486 WO2014107722A1 (en) 2013-01-07 2014-01-07 Manganese-based magnetic resonance contrast agents

Publications (1)

Publication Number Publication Date
PL2941434T3 true PL2941434T3 (pl) 2021-09-06

Family

ID=51062506

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14735166T PL2941434T3 (pl) 2013-01-07 2014-01-07 Środki kontrastujące na bazie manganu do rezonansu magnetycznego

Country Status (15)

Country Link
US (2) US20150336996A1 (pl)
EP (1) EP2941434B1 (pl)
CN (1) CN105492449B (pl)
CY (1) CY1124501T1 (pl)
DK (1) DK2941434T3 (pl)
ES (1) ES2871852T3 (pl)
HR (1) HRP20210723T1 (pl)
HU (1) HUE054111T2 (pl)
LT (1) LT2941434T (pl)
PL (1) PL2941434T3 (pl)
PT (1) PT2941434T (pl)
RS (1) RS61869B1 (pl)
SI (1) SI2941434T1 (pl)
SM (1) SMT202100304T1 (pl)
WO (1) WO2014107722A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2941434T3 (pl) 2013-01-07 2021-09-06 The General Hospital Corporation Środki kontrastujące na bazie manganu do rezonansu magnetycznego
GB201409317D0 (en) * 2014-05-26 2014-07-09 Univ Dublin Chiral compounds
US10233205B2 (en) 2015-08-07 2019-03-19 Auburn University Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species
JP7523883B2 (ja) 2015-08-13 2024-07-29 ザ ジェネラル ホスピタル コーポレイション 分子ｍｒイメージング用マンガン系キレートコンジュゲート
CN105424938A (zh) * 2015-11-09 2016-03-23 南昌大学 一种基于KMnF4纳米探针的NMR病毒快速检测方法
WO2017147418A1 (en) 2016-02-24 2017-08-31 Ohio State Innovation Foundation Methods and devices for contrast agent magnetic resonance imaging
CN106187800B (zh) * 2016-07-05 2018-04-24 川北医学院 一种含有邻二酚羟基的类edta配体和非钆磁共振造影剂及其制备方法
CN113372384B (zh) * 2020-02-25 2022-10-11 广州平澜医疗科技有限公司 磁共振造影剂及其制备方法和应用
CN111973572A (zh) * 2020-06-11 2020-11-24 浙江大学 一种基于锰基的树枝状大分子复合纳米材料、制备方法及应用
WO2022235768A1 (en) 2021-05-04 2022-11-10 Sachem, Inc. Strong binding metal-chelating resins
WO2022235769A1 (en) 2021-05-04 2022-11-10 Sachem, Inc. Strong binding metal-chelating resins using macrocycle molecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622420A (en) * 1980-03-18 1986-11-11 The Regents Of The University Of California Chelating agents and method
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
NO884225L (no) * 1987-09-25 1989-03-28 Salutar Inc Nmr-bildedannelse mn(ii)- koordinasjonsforbindelser.
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
CN1687181A (zh) 2005-04-18 2005-10-26 南京大学 含二亚乙基三胺五乙酸的可生物降解聚酯大分子配体及其制法和用途
GB0700999D0 (en) 2007-01-18 2007-02-28 Ntnu Technology Transfer As Magnetic resonance imaging
PL2941434T3 (pl) 2013-01-07 2021-09-06 The General Hospital Corporation Środki kontrastujące na bazie manganu do rezonansu magnetycznego

Also Published As

Publication number Publication date
CN105492449A (zh) 2016-04-13
US20150336996A1 (en) 2015-11-26
WO2014107722A1 (en) 2014-07-10
RS61869B1 (sr) 2021-06-30
PT2941434T (pt) 2021-05-28
EP2941434A4 (en) 2016-08-24
CN105492449B (zh) 2018-02-27
US9944668B2 (en) 2018-04-17
SI2941434T1 (sl) 2021-08-31
HUE054111T2 (hu) 2021-08-30
EP2941434A1 (en) 2015-11-11
ES2871852T3 (es) 2021-11-02
EP2941434B1 (en) 2021-03-24
HK1223622A1 (zh) 2017-08-04
DK2941434T3 (da) 2021-05-25
CY1124501T1 (el) 2022-07-22
US20150336997A1 (en) 2015-11-26
SMT202100304T1 (it) 2021-07-12
LT2941434T (lt) 2021-06-10
HRP20210723T1 (hr) 2021-06-11

Similar Documents

Publication Publication Date Title
PL2941434T3 (pl) Środki kontrastujące na bazie manganu do rezonansu magnetycznego
IL250933A0 (en) Ferromagnetic augmentation for magnetic resonance imaging
HUE056328T2 (hu) Új gadolínium kelát vegyületek mágneses rezonanciás képalkotásban történõ alkalmazásra
DK3004838T3 (da) Billeddannende cytometer
EP2951642A4 (en) OMNISTEREO IMAGING
EP2988668A4 (en) Magnetic resonance maps for analyzing tissue
HUE036581T2 (hu) Anti-FCRH5 antitestek
DK3708583T3 (da) Ikke-fucosylerede anti-fgfr2iiib-antistoffer
DK3273450T3 (da) Magnetapparat
SG11201600956QA (en) Coil assembly for magnetic resonance imaging
EP2960538A4 (en) Magnetic brake
EP2967478A4 (en) ON THE BODY PORTABLE ELECTROMAGNETIC TOMOGRAPHIC IMAGING
DK3068800T3 (da) FcRn-specifikke antistoffer
HUE046194T2 (hu) 18F-jelölt PSMA-célzott PET képalkotó ágensek
EP3030211C0 (en) MAGNETIC TRANSPORT SYSTEM
EP3048970A4 (en) Magnetic resonance imaging apparatus
DK3065774T3 (da) Anti-CCL17-antistoffer
EP3005943A4 (en) Novel magnetic resonance image technique for imaging and evaluating collateral circulation
DE112014004044A5 (de) Rektalspule für Magnet-Resonanz-Tomographie
DE112013005596A5 (de) Magnetisches Resonanz-tomographisches Gerät
DE102014221388B8 (de) Ladezustands-Berechungsvorrichtung
EP3511466C0 (en) Infinity shape coils
DE112014004884A5 (de) Schaltbare Magnetkupplung
BR112016005246A2 (pt) Solenoide
BR112016000334A2 (pt) Filtro de partícula magnética comutável